Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
53 hedge funds and large institutions have $19.7M invested in Vaxart in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 53 → 53 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
22% less capital invested
Capital invested by funds: $25.4M → $19.7M (-$5.71M)
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$725K |
| 2 |
SAM
Senzar Asset Management
New York
|
+$210K |
| 3 |
KAM
Krensavage Asset Management
New York
|
+$112K |
| 4 |
Renaissance Technologies
New York
|
+$44K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$571K |
| 2 |
Goldman Sachs
New York
|
-$132K |
| 3 |
Millennium Management
New York
|
-$81.6K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$64.3K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$13.5K |
VXRT Hedge Fund Activity: Q1 2016 in Review
53 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2016, worth a combined $19.7M — down 22% from $25.4M a quarter earlier.
Fund positioning in VXRT was balanced in Q1 2016: 5 funds opened new positions, 5 closed out, 11 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $725K. The largest seller was Fidelity Investments, cutting an estimated $571K.
- 53 institutional investors held Vaxart (VXRT) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $19.7M of Vaxart stock for Q1 2016, down 22% quarter-over-quarter.
- 5 funds opened new Vaxart positions in Q1 2016 and 5 closed out, a net change of 0 holders.
- The largest Vaxart buyer in Q1 2016 was Vanguard Group, an estimated $725K added.
- The largest Vaxart seller in Q1 2016 was Fidelity Investments, an estimated $571K sold.
Based on aggregated 13F filings for Q1 2016.